233 results on '"Hansen, John‐Bjarne"'
Search Results
2. Proportion of venous thromboembolism attributed to recognized prothrombotic genotypes in men and women
3. Galectin-3-binding protein and future venous thromboembolism
4. Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity
5. “C1-inhibitor levels and Venous Thromboembolism: Results from a Mendelian Randomization Study”: comment from Grover et al
6. “High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism”: reply
7. Combined effect of high factor VIII levels and high mean platelet volume on the risk of future incident venous thromboembolism
8. Sustained and intermittent hypoxia differentially modulate primary monocyte immunothrombotic responses to IL-1β stimulation
9. Plasma levels of P-selectin and future risk of incident venous thromboembolism
10. The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study
11. Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study
12. Diagnostic Blood Biomarkers for Acute Pulmonary Embolism: A Systematic Review
13. Surgery As a Trigger for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study
14. High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism
15. Hand grip strength in venous thromboembolism: risk of recurrence and mortality
16. Venous thromboembolism and risk of depression: a population-based cohort study
17. VTE epidemiology and challenges for VTE prevention at the population level
18. Complement factors B, D, C3bBbP and risk of future venous thromboembolism
19. Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry
20. Optimized workflow to modify microRNA expression in primary human intravascular cells
21. Impact of the von Willebrand factor-ADAMTS13 axis on the risk of future venous thromboembolism
22. C1 inhibitor deficiency enhances contact pathway mediated activation of coagulation and venous thrombosis
23. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
24. C1 Inhibitor Deficiency Results in Increased Activation of Coagulation and Enhanced Venous Thrombosis
25. Hand grip strength and risk of incident venous thromboembolism: The Tromsø study
26. Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
27. Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review
28. Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
29. A systematic review of biomarkers among hospitalized patients with COVID‐19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH
30. Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism
31. Multi‐phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations
32. Joint Effect of Multiple Prothrombotic Genotypes and Mean Platelet Volume on the Risk of Incident Venous Thromboembolism
33. Plasma levels of platelet‐derived microvesicles are associated with risk of future venous thromboembolism
34. Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial
35. A rapid, sensitive, and specific assay to measure TF activity based on chromogenic determination of thrombin generation
36. The Interaction Between Venous Thromboembolism and Socioeconomic Status on the Risk of Disability Pension
37. Effect of lower‐leg trauma and knee arthroscopy on procoagulant phospholipid‐dependent activity
38. Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors
39. Combined effects of plasma von Willebrand factor and platelet measures on the risk of incident venous thromboembolism
40. Socioeconomic status and risk of incident venous thromboembolism
41. Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
42. Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism
43. Elevated plasma concentration of complement factor C5 is associated with risk of future venous thromboembolism
44. The Risk of Venous Thromboembolism Attributed to Established Prothrombotic Genotypes
45. Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death
46. Coffee Consumption and Risk of Venous Thromboembolism
47. Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort
48. Abstract 110: C1 Esterase Inhibitor Functions As An Anticoagulant In Human And Murine Venous Thrombosis
49. Prothrombotic genotypes and risk of venous thromboembolism in occult cancer
50. Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: A population-based cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.